We analysed individual level data from pregnant women prospectively enrolled from 18 countries in two consecutive cohorts between 2020 and 2022 during the COVID-19 pandemic using identical methodology ...

A sweeping global review led by researchers at the University of British Columbia has found that mRNA vaccines—now ...

RNA vaccines represent a transformative advance in vaccinology, combining rapid development timelines, scalable manufacturing ...

Find out about the COVID-19 vaccines, the benefits of COVID-19 vaccination and the possible side effects.

Novavax (NVAX) stock is in focus as Shah Capital again slams the company's leadership despite shareholder backing at the AGM. Read more here.

Bhattacharya attacked study's test-negative design, a staple of vaccine effectiveness rese ...

Moderna (MRNA) has surged 94% in 2026 so far, crushing Pfizer (PFE) at just +4% and beating Novavax (NVAX) at +41%, as Moderna's leadership restructuring has signaled a 2027-2028 product launch push.

The COVID-19 vaccine lowered the risk of cardiovascular issues associated with the virus by around 40 percent, according to new research. The study, which was published in JAMA Internal Medicine on ...

The coronavirus vaccine reduced the risk of major cardiovascular events linked to covid-19 - strokes, heart attacks, and hospitalization from heart disease - by about 40 percent, according to a new ...

Share on Pinterest What does the ‘world-first’ vaccine designed by artificial intelligence mean for public health? Image credit: Luis Velasco/Getty Images Researchers at the University of Cambridge ...

Although most Americans have eschewed seasonal COVID-19 vaccines, the updated shots continue to show significant protection against cardiovascular disease, especially for those over age 75 and those ...

A vial of the Phase 3 Novavax coronavirus vaccine is seen ready for use in the trial at St. George's University hospital in London, on Oct. 7, 2020. (Alastair Grant/AP) (CN) — Billions of euros, ...